Dialysis Clinical Trials in Beijing, Beijing Municipality
7 recruitingBeijing, Beijing Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Phase 1Phase 2
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.12 enrolled1 locationNCT07201467
Recruiting
Phase 4
Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Dialysis; ComplicationsChronic Kidney Disease 5DRenal Anemia of Chronic Kidney Disease+2 more
Chinese PLA General Hospital240 enrolled1 locationNCT07045155
Recruiting
Not Applicable
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
End Stage Renal Disease on Dialysis
Peking University People's Hospital34 enrolled1 locationNCT07111260
Recruiting
Not Applicable
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients
Hemodialysis Complication
Peking University First Hospital60 enrolled1 locationNCT06975995
Recruiting
AI-Driven Prediction of Dialysis Outcome With EHR
Dialysis Patients
The Eye Hospital of Wenzhou Medical University1,000,000 enrolled1 locationNCT06791447
Recruiting
Phase 4
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Vitamin D DeficiencyPeritoneal Dialysis-associated Peritonitis
Peking University First Hospital176 enrolled1 locationNCT05860270